RE: Results show sizeable discount to NAV8 Dec 2021 07:46
Rivaldo,
In the latest info I have Kromek and Altair Med have gone missing. See the following:
Intuitive Investments Group - Publicly Traded Investments as at 30 November 2021:
Cost/Gain/Unrealised Gain(loss) in £
EVG: 175,110/123,234/(51,876)
MSYS: 214,500/321,750/107,250
MTPH: 99,848/74,025/(25,823)
LST: 1,078,060/2,914,960/1,836,900
POLX: 250,000/230,000/(20,000)
STX: 250,060/278,400/28,340
TRLS: 190,038/248,425/58,387
YGEN: 248,765/197,798/(50,967)
Intuitive Investments Group – Pre-IPO & Unquoted Investments as at 30 November 2021
Pre-IPO and later stage investments
BioQ Pharma Incorporated: US$1m in CLNs & warrants, 8.85% of NAV
Series A and B investments
Axol Bioscience Ltd: £249,091 in ‘A’ ordinary shares, 2.77% of NAV
CardiNor AS: £125,002 in ordinary shares, 1.39% of NAV
The Electrospinning Company Ltd: £500,000 in ordinary shares, 5.56% of NAV
Micrima Ltd: £200,000 by way of CLNs, 2.34% of NAV
Momentum Bioscience Ltd: £125,000 in preferred A ord. shares, 1.39% of NAV
PneumoWave Ltd: £350,000 in new ordinary shares, 3.89% of NAV